Stark | Jotup

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT

Retrieved on:

Wednesday, August 24, 2022

U.S. Department of Commerce Office of Security, Battle of Saint-Fulgent, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, LLP, Stark, Anti-Kickback Statute, Disclosure, U.S. Securities and Exchange Commission, GLOBE, Justice, Company, Genetics, News, Remuneration, Pomerantz, Private investigator

NEW YORK, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ:FLGT).

Key Points:

NEW YORK, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ:FLGT).
Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
The investigation concerns whether Fulgent and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Farmers National Banc Corp. Announces Holding Company Leadership Change

Retrieved on:

Wednesday, August 24, 2022

Farmers National Banc Corp. (NASDAQ: FMNB) (Farmers) has announced that Terry A. Moore has assumed the role of Chairman of the Board, effective September 1, 2022.

Key Points:

Farmers National Banc Corp. (NASDAQ: FMNB) (Farmers) has announced that Terry A. Moore has assumed the role of Chairman of the Board, effective September 1, 2022.
View the full release here: https://www.businesswire.com/news/home/20220823005617/en/
Mr. Moore also serves on the Compensation Committee and Corporate Governance & Nominating Committee and will Chair the Executive Committee for Farmers National Banc Corp.
Mr. Moore joined the Farmers National Banc Corp Board of Directors in April 2014.
Founded in 1887, Farmers National Banc Corp. is a diversified financial services company headquartered in Canfield, Ohio, with $4.1 billion in banking assets.
Farmers National Banc Corp.s wholly-owned subsidiaries are comprised of The Farmers National Bank of Canfield, a full-service national bank engaged in commercial and retail banking with 46 banking locations in Mahoning, Trumbull, Columbiana, Stark, Summit, Portage, Wayne, Medina, Geauga and Cuyahoga counties in Ohio and Beaver County in Pennsylvania; Farmers Trust Company, which operates five trust offices and offers services in the same geographic markets and Farmers National Insurance, LLC.

Farmers National Banc Corp. Declares Quarterly Cash Dividend

Retrieved on:

Tuesday, August 23, 2022

Finance, Banking, Professional Services, Other Professional Services, Insurance, NASDAQ, Stark, Board, Board of directors, Farmers National Bank, Farmer, LLC, Bank, Cuyahoga

On August 23, 2022, the Board of Directors of the Farmers National Banc Corp. (NASDAQ: FMNB) declared a quarterly cash dividend of $0.16 per share.

Key Points:

On August 23, 2022, the Board of Directors of the Farmers National Banc Corp. (NASDAQ: FMNB) declared a quarterly cash dividend of $0.16 per share.
ABOUT FARMERS NATIONAL BANC CORP.
Founded in 1887, Farmers National Banc Corp. is a diversified financial services company headquartered in Canfield, Ohio, with $4.1 billion in banking assets.
Farmers National Banc Corp.s wholly-owned subsidiaries are comprised of The Farmers National Bank of Canfield, a full-service national bank engaged in commercial and retail banking with 46 banking locations in Mahoning, Trumbull, Columbiana, Stark, Summit, Portage, Wayne, Medina, Geauga and Cuyahoga counties in Ohio and Beaver County in Pennsylvania; Farmers Trust Company, which operates five trust offices and offers services in the same geographic markets and Farmers National Insurance, LLC.

Bragar Eagel & Squire, P.C. Is Investigating Cassava, U.S. Bancorp, Fulgent, and Generac and Encourages Investors to Contact the Firm

Retrieved on:

Monday, August 22, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points:

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
On April 18, 2022, The New York Times published an article entitled Scientists Question Data Behind an Experimental Alzheimers Drug.
The article addressed Cassavas experimental Alzheimers drug, simufilam, and reported that one of Cassavas advisers, Dr. H.Y.
For more information on the Generac investigation go to: https://bespc.com/cases/GNRC
About Bragar Eagel & Squire, P.C.

Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of Fulgent Genetics, Inc. (FLGT) Investors

Retrieved on:

Thursday, August 18, 2022

GLOBE, Cancer, Anti-Kickback Statute, SEC, DOJ, Kirby, Securities Exchange Act of 1934, Remuneration, Genetics, Battle of Saint-Fulgent, Company, Exchange, NASDAQ, News, Mutation, Stark, Private investigator

NEW YORK, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ).

Key Points:

NEW YORK, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ).
The investigation concerns whether Fulgent has violated the federal securities laws and/or engaged in other unlawful business practices.
Based on this news, the price of Fulgent shares declined from $63.74 per share to $59.86 on August 5, 2022.
Kirby McInerney LLP is a New York-based plaintiffs law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.

Bragar Eagel & Squire, P.C. Is Investigating Fulgent, Generac, Atara, and Clariant and Encourages Investors to Contact the Firm

Retrieved on:

Tuesday, August 16, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points:

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
As part of its release, the Company disclosed that the SEC is investigating certain Exchange Act reports for 2018 through the first quarter of 2020.
Based on this news, shares of Fulgent fell by $3.34 per share, or 5.3%, to close at $59.86 per share on August 5, 2022.
On this news, shares of Clariant AG ADR shares fell more than 14% in intraday trading on February 14, 2022.

Bragar Eagel & Squire, P.C. Is Investigating U.S. Bancorp, Fulgent, the WWE, and F45 and Encourages Investors to Contact the Firm

Retrieved on:

Thursday, August 11, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points:

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
On May 4, 2021, the Company announced an investigation by the CFPB into its sales practices.
Then, on July 26, 2022, F45 issued a press release entitled F45 Training Announces Strategic Update.
For more information on the F45 investigation go to: https://bespc.com/cases/FXLV
About Bragar Eagel & Squire, P.C.

Fulgent Genetics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Retrieved on:

Wednesday, August 10, 2022

GLOBE, Anti-Kickback Statute, SEC, Securities Exchange Act of 1934, Remuneration, Battle of Saint-Fulgent, Genetics, Review, U.S. Department of Justice Office of Legislative Affairs, Privacy Office of the U.S. Department of Homeland Security, Company, Exchange, NASDAQ, News, Stark, Justice

LOS ANGELES, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors.

Key Points:

LOS ANGELES, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors.
Fulgent investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors options for pursuing claims to recover their losses.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm

Retrieved on:

Tuesday, August 9, 2022

Legal, Professional Services, P.C, Telephone, Anti-Kickback Statute, SEC, DOJ, Securities Exchange Act of 1934, Remuneration, Genetics, Battle of Saint-Fulgent, Company, Exchange, NASDAQ, Jeanne Eagels, News, Stark, Private investigator

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) on behalf of Fulgent stockholders.

Key Points:

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) on behalf of Fulgent stockholders.
Our investigation concerns whether Fulgent has violated the federal securities laws and/or engaged in other unlawful business practices.
Fulgent released its financial results for the second quarter of 2022 on August 4, 2022.
The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

Retrieved on:

Monday, August 8, 2022

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) investors concerning the Companys possible violations of the federal securities laws.

Key Points:

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) investors concerning the Companys possible violations of the federal securities laws.
On this news, Fulgents stock fell as much as 8% during intraday trading on August 5, 2022, thereby injuring investors.
Whistleblower Notice: Persons with non-public information regarding Fulgent should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.
Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.